Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22


Human iPSC-Derived Neurons and Cerebral Organoids Establish Differential Effects of Germline NF1 Gene Mutations.

Anastasaki C, Wegscheid ML, Hartigan K, Papke JB, Kopp ND, Chen J, Cobb O, Dougherty JD, Gutmann DH.

Stem Cell Reports. 2020 Mar 20. pii: S2213-6711(20)30097-7. doi: 10.1016/j.stemcr.2020.03.007. [Epub ahead of print]


Commentary: Identification of Mutation Regions on NF1 Responsible for High- and Low-Risk Development of Optic Pathway Glioma in Neurofibromatosis Type I.

Anastasaki C, Gao F, Gutmann DH.

Front Genet. 2019 Mar 1;10:115. doi: 10.3389/fgene.2019.00115. eCollection 2019. No abstract available.


Neurofibromatosis type 1 (Nf1)-mutant mice exhibit increased sleep fragmentation.

Anastasaki C, Rensing N, Johnson KJ, Wong M, Gutmann DH.

J Sleep Res. 2019 Aug;28(4):e12816. doi: 10.1111/jsr.12816. Epub 2019 Jan 4.


Independent NF1 mutations underlie café-au-lait macule development in a woman with segmental NF1.

Freret ME, Anastasaki C, Gutmann DH.

Neurol Genet. 2018 Jul 23;4(4):e261. doi: 10.1212/NXG.0000000000000261. eCollection 2018 Aug. No abstract available.


Children with 5'-end NF1 gene mutations are more likely to have glioma.

Anastasaki C, Morris SM, Gao F, Gutmann DH.

Neurol Genet. 2017 Sep 22;3(5):e192. doi: 10.1212/NXG.0000000000000192. eCollection 2017 Oct.


Characterization of early communicative behavior in mouse models of neurofibromatosis type 1.

Maloney SE, Chandler KC, Anastasaki C, Rieger MA, Gutmann DH, Dougherty JD.

Autism Res. 2018 Jan;11(1):44-58. doi: 10.1002/aur.1853. Epub 2017 Aug 26.


Updated nomenclature for human and mouse neurofibromatosis type 1 genes.

Anastasaki C, Le LQ, Kesterson RA, Gutmann DH.

Neurol Genet. 2017 Jul 26;3(4):e169. doi: 10.1212/NXG.0000000000000169. eCollection 2017 Aug. No abstract available.


KIR2DL5 mutation and loss underlies sporadic dermal neurofibroma pathogenesis and growth.

Anastasaki C, Dahiya S, Gutmann DH.

Oncotarget. 2017 Jul 18;8(29):47574-47585. doi: 10.18632/oncotarget.17736.


Human stem cell modeling in neurofibromatosis type 1 (NF1).

Wegscheid ML, Anastasaki C, Gutmann DH.

Exp Neurol. 2018 Jan;299(Pt B):270-280. doi: 10.1016/j.expneurol.2017.04.001. Epub 2017 Apr 6. Review.


Mice with missense and nonsense NF1 mutations display divergent phenotypes compared with human neurofibromatosis type I.

Li K, Turner AN, Chen M, Brosius SN, Schoeb TR, Messiaen LM, Bedwell DM, Zinn KR, Anastasaki C, Gutmann DH, Korf BR, Kesterson RA.

Dis Model Mech. 2016 Jul 1;9(7):759-67. doi: 10.1242/dmm.025783. Epub 2016 Jun 2.


Contextual signaling in cancer.

Smithson LJ, Anastasaki C, Chen R, Toonen JA, Williams SB, Gutmann DH.

Semin Cell Dev Biol. 2016 Oct;58:118-26. doi: 10.1016/j.semcdb.2016.06.002. Epub 2016 Jun 3. Review.


NF1 germline mutation differentially dictates optic glioma formation and growth in neurofibromatosis-1.

Toonen JA, Anastasaki C, Smithson LJ, Gianino SM, Li K, Kesterson RA, Gutmann DH.

Hum Mol Genet. 2016 May 1;25(9):1703-13. doi: 10.1093/hmg/ddw039. Epub 2016 Feb 16.


MEK Inhibitors Reverse cAMP-Mediated Anxiety in Zebrafish.

Lundegaard PR, Anastasaki C, Grant NJ, Sillito RR, Zich J, Zeng Z, Paranthaman K, Larsen AP, Armstrong JD, Porteous DJ, Patton EE.

Chem Biol. 2015 Oct 22;22(10):1335-46. doi: 10.1016/j.chembiol.2015.08.010. Epub 2015 Sep 17.


Elucidating the impact of neurofibromatosis-1 germline mutations on neurofibromin function and dopamine-based learning.

Anastasaki C, Woo AS, Messiaen LM, Gutmann DH.

Hum Mol Genet. 2015 Jun 15;24(12):3518-28. doi: 10.1093/hmg/ddv103. Epub 2015 Mar 18.


Neuronal NF1/RAS regulation of cyclic AMP requires atypical PKC activation.

Anastasaki C, Gutmann DH.

Hum Mol Genet. 2014 Dec 20;23(25):6712-21. doi: 10.1093/hmg/ddu389. Epub 2014 Jul 28.


DHX34 and NBAS form part of an autoregulatory NMD circuit that regulates endogenous RNA targets in human cells, zebrafish and Caenorhabditis elegans.

Longman D, Hug N, Keith M, Anastasaki C, Patton EE, Grimes G, Cáceres JF.

Nucleic Acids Res. 2013 Sep;41(17):8319-31. doi: 10.1093/nar/gkt585. Epub 2013 Jul 4.


Continual low-level MEK inhibition ameliorates cardio-facio-cutaneous phenotypes in zebrafish.

Anastasaki C, Rauen KA, Patton EE.

Dis Model Mech. 2012 Jul;5(4):546-52. doi: 10.1242/dmm.008672. Epub 2012 Feb 2.


Dhx34 and Nbas function in the NMD pathway and are required for embryonic development in zebrafish.

Anastasaki C, Longman D, Capper A, Patton EE, Cáceres JF.

Nucleic Acids Res. 2011 May;39(9):3686-94. doi: 10.1093/nar/gkq1319. Epub 2011 Jan 11.


Combined zebrafish-yeast chemical-genetic screens reveal gene-copper-nutrition interactions that modulate melanocyte pigmentation.

Ishizaki H, Spitzer M, Wildenhain J, Anastasaki C, Zeng Z, Dolma S, Shaw M, Madsen E, Gitlin J, Marais R, Tyers M, Patton EE.

Dis Model Mech. 2010 Sep-Oct;3(9-10):639-51. doi: 10.1242/dmm.005769. Epub 2010 Aug 16.


A novel role for Glucocorticoid-Induced TNF Receptor Ligand (Gitrl) in early embryonic zebrafish development.

Poulton LD, Nolan KF, Anastasaki C, Waldmann H, Patton EE.

Int J Dev Biol. 2010;54(5):815-25. doi: 10.1387/ijdb.082841lp.


Kinase-activating and kinase-impaired cardio-facio-cutaneous syndrome alleles have activity during zebrafish development and are sensitive to small molecule inhibitors.

Anastasaki C, Estep AL, Marais R, Rauen KA, Patton EE.

Hum Mol Genet. 2009 Jul 15;18(14):2543-54. doi: 10.1093/hmg/ddp186. Epub 2009 Apr 17.


The INT6 cancer gene and MEK signaling pathways converge during zebrafish development.

Grzmil M, Whiting D, Maule J, Anastasaki C, Amatruda JF, Kelsh RN, Norbury CJ, Patton EE.

PLoS One. 2007 Sep 26;2(9):e959.

Supplemental Content

Loading ...
Support Center